Skip to main content
The Guideline Writing Group and Systematic Review Group reported the following disclosures during development and approval of this guideline:
Dr. Reus is employed as a professor of psychiatry at the University of California, San Francisco School of Medicine. He is past Chairman of the Board of the Accreditation Council for Continuing Medical Education (ACCME). He receives travel funds from the ACCME and the American Board of Psychiatry and Neurology (ABPN) for board meetings and test development. He receives research grant support from the National Institute of Mental Health (NIMH) and National Institute on Drug Abuse and honoraria for NIMH grant review service. He reports no conflicts of interest with his work on this guideline.
Dr. Fochtmann is employed as a professor of psychiatry, pharmacological sciences, and biomedical informatics at Stony Brook University. She consults for the American Psychiatric Association on the development of practice guidelines and has received travel funds to attend meetings related to these duties. She reports no conflicts of interest with her work on this guideline.
Dr. Bukstein is employed by Boston Children’s Hospital, where he is Vice Chair for the Department of Psychiatry. He is also a professor of psychiatry at Harvard Medical School. He has received royalties from Taylor Francis Press and Wolters Kluwer. He is co-chair of the Committee on Quality Issues of the American Academy of Child and Adolescent Psychiatry. He reports no conflicts of interest with his work on this guideline.
Dr. Eyler is employed as a professor of psychiatry and family medicine at the Robert Larner, MD, College of Medicine at the University of Vermont in Burlington, Vermont, and as an attending psychiatrist at the University of Vermont Medical Center and its affiliated hospitals. During the period of preparation of this guideline, he received honoraria from non-industry-sponsored academic and community presentations. He has provided clinical consultation on gender dysphoria to the Department of Corrections of the state of New Hampshire and general psychiatric consultation at The Health Center, a federally qualified health center in Plainfield, Vermont. He is a member of the advisory committee of the Samara Fund, a philanthropic group serving the LGBT communities in Vermont. He has received fees or royalties from Johns Hopkins University Press, Taylor & Francis, and Healthwise, Inc. Travel funds have been provided by the American Psychiatric Association, related to service on the Assembly Executive Committee. He reports no conflicts of interest with his work on this guideline.
Dr. Hilty is employed as a professor of psychiatry at the University of Southern California. He reports no conflicts of interest with his work on this guideline.
Dr. Horvitz-Lennon is employed as a physician scientist at the RAND Corporation, as a professor at the Pardee RAND Graduate School, and as an attending psychiatrist with Cambridge Health Alliance. She reports no conflicts of interest with her work on this guideline.
Dr. Mahoney is employed as a researcher and clinical nurse specialist at The Menninger Clinic in Houston, Texas. She is also an associate professor in the Department of Psychiatry and Behavioral Sciences at Baylor College of Medicine. She reports no conflicts of interest with her work on this guideline.
Dr. Pasic is employed as a professor of psychiatry at the University of Washington. She is a member of the board of the American Association of Emergency Psychiatry. She reports no conflicts of interest with her work on this guideline.
Dr. Weaver is employed as a professor of psychiatry and medical director of the Center for Neurobehavioral Research on Addiction at The University of Texas Health Science Center at Houston. He receives research grant support from the National Institute on Drug Abuse. He is Chair of the Addiction Medicine Sub-board for the American Board of Preventive Medicine. He is a member of the Publications Council and the Annual Conference Committee for the American Society of Addiction Medicine. He is a member of the Behavioral Health Advisory Committee for the Texas Children’s Health Plan. He receives travel funds from The Addiction Medicine Foundation for presentations and exam development and from The Joint Commission as a member of a technical advisory panel. He receives royalties from UpToDate as a content author. He occasionally provides medical expert witness consultation for legal cases. During the period of preparation of this guideline, he received honoraria from the U.S. Drug Enforcement Administration. He reports no conflict of interest with his work on this guideline.
Dr. Wills is employed as an assistant professor of psychiatry at University Hospitals, Case Medical Center. She also has a private practice in forensic psychiatry. She receives no royalties from any entity. She receives travel funds but no honoraria from the American Academy of Psychiatry and the Law. She provides medicolegal consultation and expert testimony to courts. She reports no conflicts of interest with her work on this guideline.
Dr. Kidd is employed as a fourth-year resident in psychiatry at New York Presbyterian (Columbia University), Columbia University Medical Center, and the New York State Psychiatric Institute. He is a member of the APA Council on Quality Care, the Area 2 Resident-Fellow Member Representative to the APA Assembly, and the Chair of the APA/APAF Leadership fellowship, for which he receives travel funds. He reports no conflicts of interest with his work on this guideline.
Dr. McIntyre is a clinical professor of psychiatry at the University of Rochester. He is in full-time private practice and is Medical Director of HCR, a home health care agency. Dr. McIntyre is the Chair of the Board of PCPI and Chair of the Quality Collaborative of Monroe County Medical Society. He serves on the boards of several other not-for-profit organizations. He reports no conflicts of interest with his work on this guideline.
Dr. Yager is employed as a professor of psychiatry at the University of Colorado. He reports no conflicts of interest with his work on this guideline.
Ms. Hong is employed as a research manager for the practice guidelines program at American Psychiatric Association. She reports no conflicts of interest with her work on this guideline.

Information & Authors

Information

Published In

Go to The American Psychiatric Association Practice Guideline for                     the Pharmacological Treatment of Patients With Alcohol Use                     Disorder
The American Psychiatric Association Practice Guideline for the Pharmacological Treatment of Patients With Alcohol Use Disorder
January 2018
©American Psychiatric Association Publishing

Authors

Metrics & Citations

Metrics

Citations

If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Simply select your manager software from the list below and click Download.

For more information or tips please see 'Downloading to a citation manager' in the Help menu.

Format
Citation style
Style
Copy to clipboard

View Options

View options

Login options

Already a subscriber? Access your subscription through your login credentials or your institution for full access to this article.

Personal login Institutional Login Open Athens login

Not a subscriber?

Subscribe Now / Learn More

PsychiatryOnline subscription options offer access to the DSM-5-TR® library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing [email protected] or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

Media

Figures

Other

Tables

Share

Share

Share article link

Share